Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02333110
NA

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

View on ClinicalTrials.gov

Summary

Palliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor size, tumor location and tumor pathology. However, for many patients this treatment involves considerable toxicity, travel and time spent at the hospital. Spatially fractionated radiation (SFR) is an alternative technique that consists in delivering one single treatment, given through a grid containing holes. The present study is proposing to validate SFR as a safe and effective mean to palliate patients with symptomatic bulky tumors (more than 8 cm) or with tumors known to be resistant to radiation.

Official title: Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2015-01

Completion Date

2027-12

Last Updated

2026-05-12

Healthy Volunteers

No

Interventions

RADIATION

spatially fractionated radiation therapy

A single dose of 15-20Gys of spatially fractionated radiation therapy

Locations (1)

Sir Mortimer Jewish General Hospital

Montreal, Quebec, Canada